| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Ayer Capital Management, LP serves as a 10% Owner at IOVA. Across recent SEC filings that breaks down to 0 buys and 1 sell. Those positions are worth an estimated $27.2M at current prices.
The biggest single holding is IOVA (~$27.2M) as 10% Owner. The recent filings there lean toward selling, a net 2,780,682 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 1, 2015 | IOVA Iovance Biotherapeutics, Inc. | 10% Owner | Sell | 2,780,682 | $9.62 | $26,752,385.39 | -49.6% |